Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults
Información
- DOI:
- https://doi.org/10.1002/14651858.CD013044Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 07 junio 2018see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Problemas de desarrollo, psicosociales y de aprendizaje
- Copyright:
-
- Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Franco De Crescenzo and Liliya Eugenevna Ziganshina drafted the protocol and have overall responsibility for the review. All authors contributed to writing the protocol.
Sources of support
Internal sources
-
Kazan Federal University, Russian Federation.
Employer of Liliya Ziganshina and Ekaterina V Yudina
-
Catholic University of the Sacred Heart, Rome, Italy.
Employer of Franco De Crescenzo
-
Izmir Katip Celebi University, Izmir, Turkey.
Employer of Yusuf Cem Kaplan
-
Tor Vergata University, Rome, Italy.
Employer of Marco Ciabattini
External sources
-
Ministry of Education and Research of the Russian Federation, Russian Federation.
This work is performed according to the Russian Government Program of Competitive Growth of Kazan Federal University.
Declarations of interest
Franco De Crescenzo: none known.
Liliya Eugenevna Ziganshina is the Director of Cochrane Russia. It should be noted that no funding was administered for this review.
Ekaterina V Yudina is the Co‐Director of Cochrane Russia.
Yusuf Cem Kaplan: none known.
Marco Ciabattini: none known.
Yinghui Wei is a Statistical Editor with Cochrane Developmental, Psychosocial and Learning Problems.
Charles HV Hoyle: is a Senior Researcher at Cochrane Russia.
Acknowledgements
This protocol is one of a series of reviews investigating the effects of drug interventions for attention deficit hyperactivity disorder (ADHD) in adults. It was developed with support from Cochrane Developmental, Psychosocial and Learning Problems (CDPLP), UK, and Cochrane Nordic, Denmark.
We would like to thank Professor Geraldine Macdonald, Co‐ordinating Editor of CDPLP and Dr Joanne Duffield (née Wilson), Managing Editor of CDPLP, for their support. We would also like to thank Margaret Anderson, Information Specialist of CDPLP, who developed the search strategy and will run the searches.
We would like to thank Kim Boesen and Karsten Juhl Jørgensen of Cochrane Nordic and their co‐authors on the protocol 'Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults' (Boesen 2017b), which we used as an exemplar when developing this protocol. The protocol was discussed in detail at the Cochrane training workshop, organised by Cochrane Russia, which was led by Karsten Juhl Jørgensen.
We would also like to acknowledge the Cochrane Infectious Diseases, Stroke and Epilepsy Groups, as we used some text from the Methods sections of the published reviews from the Infectious Diseases group (Ziganshina 2013), the Stroke group (Ziganshina 2016; Ziganshina 2017a), and the protocol from the Epilepsy group (Ziganshina 2017b).
The work was performed, in part, according to the Russian Government Program of Competitive Growth, Kazan Federal University.
Version history
| Published | Title | Stage | Authors | Version |
| 2018 Jun 07 | Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults | Protocol | Franco De Crescenzo, Liliya Eugenevna Ziganshina, Ekaterina V Yudina, Yusuf Cem Kaplan, Marco Ciabattini, Yinghui Wei, Charles HV Hoyle | |
